1 1

Foundayo Pills

Foundayo Pills

Foundayo Tablets (orforglipron) are an upcoming once-daily tablet currently being studied for weight management and metabolic health support.

This oral medication belongs to a newer generation of GLP-1 based treatments designed to help reduce appetite, support healthier eating habits, and aid long-term weight management without injections.

We are closely monitoring UK availability and regulatory updates.

Register for email updates below to be among the first to hear when Foundayo Tablets become available through SwiftDoctor, including launch information, pricing updates and eligibility guidance.

View full details
Register your interest here!

Frequently asked questions

Everything you need to know before you start your weight loss journey.

What is the difference between weight loss injections and the Foundayo tablet?

Weight loss injections (such as GLP-1 injectables) are administered via weekly injections, while Foundayo tablets are an oral GLP-1 treatment taken daily. Both are designed to support appetite control and weight management, but the tablet offers a needle-free alternative that may be easier for some people to use.

When will the Foundayo tablet be available?

Foundayo tablets are currently FDA approved and in late-stage development, but are still awaiting approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK. Once regulatory approvals and rollout are complete, they are expected to become available. You can join the waiting list or place a pre-order to be notified as soon as they are available.

How do I take Foundayo tablets?

Foundayo tablets are taken once daily exactly as prescribed by your clinician. They can be taken at any time of the day, with no restrictions on food or water intake. They are part of a structured treatment plan following an online consultation.

How does the Foundayo tablet work?

Foundayo tablets work by acting on GLP-1 receptors in the body, helping to regulate appetite, increase feelings of fullness, and reduce cravings. This can support healthier eating habits and contribute to gradual, sustained weight loss when combined with diet and lifestyle changes.

What is the Foundayo pill dose?

Foundayo tablets are available in the following strengths: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. Treatment follows a gradual titration schedule to help improve tolerability. Patients typically start at 0.8 mg once daily, with dose increases guided by a clinician.

What are the ingredients in the Foundayo pills?

Foundayo tablets contain orforglipron, a GLP-1 receptor agonist currently being studied for weight management and metabolic health support. Full ingredient details will be confirmed once the medication is prescribed and supplied.

How should Foundayo tablets be stored?

Store Foundayo tablets in a cool, dry place away from direct sunlight and moisture. Always keep them out of reach of children and follow any storage instructions provided with your prescription.

What are the most common side effects of Foundayo tablets?

Commonly reported side effects may include nausea, reduced appetite, bloating, constipation, or mild digestive discomfort. These are often temporary and may improve as your body adjusts.

Who can have the Foundayo tablets?

Foundayo tablets may be suitable for adults who meet clinical criteria for weight management support. Eligibility is determined through an online consultation with a qualified clinician.

What level of support is offered while I am taking Foundayo tablets?

You’ll receive ongoing clinical support throughout treatment, including online guidance and check-ins where appropriate.

Can I switch from injections to Foundayo tablets?

Yes, patients using GLP-1 injections may be able to transition to oral GLP-1 treatment, depending on clinical assessment.

What happens if I miss a dose of the Foundayo pill?

If you miss a dose, take it as soon as you remember unless it’s close to your next dose. Do not double dose.

Are Foundayo pills effective?

Foundayo tablets are part of a new generation of GLP-1 treatments being studied for weight management. Clinical research shows promising results for appetite regulation and weight loss support when combined with lifestyle changes. Individual results vary and suitability is confirmed via consultation.